Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP) -- Ignore unavailable to you. Want to Upgrade?

To: Rob who wrote (1080)	10/29/1998 1:01:00 AM
From: David Wolfson	Read Replies (2) \| Respond to of 1501

Oh God! Not another one of these! I've already been through this with Green Oasis. Is every company I own a perpetrator of internet fraud? What is up with this? I imagine the SEC doesn't have much jurisdiction over Canadian companies, but I also imagine they can create obstacles for trading of IZP on American exchanges. Has anyone spoken to the company about this? This kind of thing really puts a damper on stock price--please someone tell me it's not really true!

To: Rob who wrote (1080)	10/29/1998 1:13:00 PM
From: Sean Janzen	Respond to of 1501

Inflazyme Pharmaceuticals Ltd. demands retraction and apology from Canada Stockwatch for false headline regarding SEC investigation. biz.yahoo.com

To: Rob who wrote (1080)	10/29/1998 4:55:00 PM
From: Chuca Marsh	Read Replies (1) \| Respond to of 1501

Rob posted the entire header...Bob 2 take a look: Internet tout targeted in SEC sweep Inflazyme Pharmaceuticals Ltd IZP Shares issued 24,997,493 Oct 28 close $0.44 Wed 28 Oct 98 Street Wire Also Nord Pacific Ltd (NPF) by Brent Mudry SURF'S UP, DUDE! An New York-based Internet tout who promoted Nord Pacific and Inflazyme Pharmaceuticals under contract is among 44 penny stock promoters targeted by the United States Securities and Exchange Commission in a massive crackdown on Internet stock promotions revealed Wednesday. Chuca2

To: Rob who wrote (1080)	10/29/1998 8:00:00 PM
From: Rob	Respond to of 1501

Hi folks, Keep your eye on the science, that's what matters. The phase 1 trials will dictate the future of this company. Toxicity studies in animals are promising but human tolerance is always unpredictable. They're moving methodically toward the trials, that's encouraging. P.S. It would appear we have a new board participant that shares my moniker, welcome! Please note that until we get this resolved I'll add a second initial at the end of my posts i.e."Rob P." Rob P. < The old timer..;) >